Healthcare -
Biotechnology - NASDAQ - US
$ 1.845
-7.18 %
$ 137 M
Market Cap
-1.67
P/E
IKT - REVENUE
Revenue IKT - Inhibikase Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR